CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 12 enrolled
Drug / intervention
Diclofenac Epolamine Patch +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03145259
NCT03145259Early Ph 1Completed
CompareCT.gov

Evaluation of Bioavailability of Diclofenac Dermal Products

University of Maryland, Baltimore·interventional·Posted May 9, 2017·Updated Jun 30, 2020

In Brief

A Early Phase 1 clinical trial evaluating Diclofenac Epolamine Patch and diclofenac sodium solution for Bioavailability. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The study will utilize already FDA-approved marketed diclofenac products in healthy adults to generate data for establishing rate of drug delivery comparisons between diclofenac epolamine patches and diclofenac sodium solution in healthy adults and to determine skin concentrations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBioavailability
CountriesUnited States
CollaboratorsFood and Drug Administration (FDA)

Timeline

Early Ph 1CompletedFinished
201820192020202120222023202420252026
First PostedMay 9, 2017
Enrollment StartApr 19, 2017
Primary CompletionAug 29, 2019
Study CompletionMay 15, 2020
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 9.1 years ago

Interventions

Diclofenac Epolamine Patchdrug

patch

diclofenac sodium solutiondrug

solution